Lilly Pulls Sarcoma Treatment Ahead of EMA Veto

Drug Industry Daily
A A
Eli Lilly on Friday pulled its sarcoma treatment Lartruvo just ahead of European regulators announcing that the antibody had failed to prove its effectiveness in a pivotal clinical trial.

To View This Article:

Login

Subscribe To Drug Industry Daily